美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=HYDROCHLOROTHIAZIDE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
HYDROCHLOROTHIAZIDE; IRBESARTAN 201616 002 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET; ORAL 12.5MG; 300MG No No 2012/09/28 (TA) -- CIPLA LIMITED None (Tentative Approval)
IRBESARTAN AND HYDROCHLOROTHIAZIDE 090351 001 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;150MG No No 2012/10/15 2012/10/15 HIKMA Prescription
IRBESARTAN AND HYDROCHLOROTHIAZIDE 090351 002 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;300MG No No 2012/10/15 2012/10/15 HIKMA Prescription
IRBESARTAN AND HYDROCHLOROTHIAZIDE 090351 003 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 25MG;300MG No No 2012/10/15 2017/06/08 HIKMA Prescription
IRBESARTAN AND HYDROCHLOROTHIAZIDE 091370 001 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;150MG No No 2012/10/15 2012/10/15 ALEMBIC Prescription
IRBESARTAN AND HYDROCHLOROTHIAZIDE 091370 002 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;300MG No No 2012/10/15 2012/10/15 ALEMBIC Prescription
IRBESARTAN AND HYDROCHLOROTHIAZIDE 091370 003 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 25MG;300MG No No 2012/10/15 2016/10/12 ALEMBIC Prescription
IRBESARTAN AND HYDROCHLOROTHIAZIDE 201505 001 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;150MG No No 2012/10/15 (TA) 2012/10/15 APOTEX INC Discontinued
IRBESARTAN AND HYDROCHLOROTHIAZIDE 201505 001 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;150MG No No 2012/10/15 2012/10/15 APOTEX INC Discontinued
IRBESARTAN AND HYDROCHLOROTHIAZIDE 201505 002 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;300MG No No 2012/10/15 (TA) 2012/10/15 APOTEX INC Discontinued
IRBESARTAN AND HYDROCHLOROTHIAZIDE 201505 002 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;300MG No No 2012/10/15 2012/10/15 APOTEX INC Discontinued
IRBESARTAN HYDROCHLOROTHIAZIDE 201505 003 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET; ORAL 25MG;300MG No No 2012/10/15 (TA) -- APOTEX INC None (Tentative Approval)
IRBESARTAN HYDROCHLOROTHIAZIDE 201505 003 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET; ORAL 25MG;300MG No No 2012/10/15 -- APOTEX INC None (Tentative Approval)
IRBESARTAN AND HYDROCHLOROTHIAZIDE 091539 001 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;150MG No No 2012/10/22 2012/10/22 WATSON LABS INC Discontinued
IRBESARTAN AND HYDROCHLOROTHIAZIDE 091539 001 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;150MG No No 2012/10/22 (TA) 2012/10/22 WATSON LABS INC Discontinued
IRBESARTAN AND HYDROCHLOROTHIAZIDE 091539 002 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;300MG No No 2012/10/22 2012/10/22 WATSON LABS INC Discontinued
IRBESARTAN AND HYDROCHLOROTHIAZIDE 091539 002 ANDA HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL 12.5MG;300MG No No 2012/10/22 (TA) 2012/10/22 WATSON LABS INC Discontinued
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 090704 001 ANDA CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE TABLET;ORAL 16MG;12.5MG No No 2012/12/04 2012/12/04 MYLAN Prescription
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 090704 002 ANDA CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE TABLET;ORAL 32MG;12.5MG No No 2012/12/04 2012/12/04 MYLAN Prescription
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 090704 003 ANDA CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE TABLET;ORAL 32MG;25MG No No 2012/12/04 2012/12/04 MYLAN Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database